Endpoint definition
↥| Name | C3_BONE_CARTILAGE | 
|---|---|
| Long name | Malignant neoplasm of bone and articular cartilage | 
| Include | C3_BONE_CARTILAGE_LIMBS, C3_BONE_CARTILAGE_NAS | 
| Level in the ICD-hierarchy | 2 | 
| First defined in version | DF4 | 
bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
| Name | C3_BONE_CARTILAGE | 
|---|---|
| Long name | Malignant neoplasm of bone and articular cartilage | 
| Include | C3_BONE_CARTILAGE_LIMBS, C3_BONE_CARTILAGE_NAS | 
| Level in the ICD-hierarchy | 2 | 
| First defined in version | DF4 | 
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 119 | 42 | 77 | 
| Unadjusted prevalence (%) | 0.05 | 0.03 | 0.08 | 
| Mean age at first event (years) | 45.49 | 47.54 | 44.37 | 
| Case fatality at 5-years (%) | 5.04 | 7.14 | 3.90 | 
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 | 
| Recurrence at 6 months (%) | 0.84 | 2.38 | - | 
						 before Malignant neoplasm of bone and articular cartilage
						
						 after Malignant neoplasm of bone and articular cartilage
					
Loading survival analyses plot…
Loading survival analyses table…